FDA Approved: DIAZEPAM — Supplemental Application (Hospira, Inc.)

View source ↗

Summary

FDA approved a supplemental application for diazepam from Hospira, Inc., under an ANDA, indicating regulatory approval of the requested changes to the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Withdrawal Syndrome
• Anxiety Disorders
• Epilepsy
• Muscle Spasticity
• Status Epilepticus

Drugs mentioned

• Diazepam (Diazepam)

Snippet

SUPPL AP for DIAZEPAM (DIAZEPAM)